Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: GENENTECH INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2025-09-11 to 2030-03-29
Current total value of award: $1085530
Description: THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO DEVELOP CAUSAL METHODOLOGIES FOR MANAGING DIVERSE MISSING DATA PATTERNS IN